Herpesvirus Vaccine
Intervet Inc. announces the availability of Prodigy? with Havlogen? as an aid in the prevention of abortion and respiratory disease associated with Equine Herpesvirus 1 (EHV-1) infection.
Intervet Inc. announces the availability of Prodigy®with Havlogen® as an aid in the prevention of abortion and respiratory disease associated with Equine Herpesvirus 1 (EHV-1) infection. EHV-1 is the leading cause of infectious viral abortions in mares.
In a EHV-1 challenge study, Prodigy vaccinated mares demonstrated 89.5 percent protection against abortions associated with EHV-1 induced infections and a 96.1 percent reduction in virus shedding from nasal exudates.
In addition, an independent research study tested adult mares with an unknown vaccination history to study the antibody and interferon-gamma responses of EHV-1 vaccines after three doses.
During the course of the study, Prodigy produced the best EHV-1 antibody response, the company says.
For fastest response, call
(800) 441-8272
